Schrodinger: A Rare AI-Adjacent Disruptor Still Not Priced For It
Schrödinger Rolls Out Early Access Version Of Bunsen
Morgan Stanley Maintains an Equal Weight” rating on Schrödinger, Inc. (SDGR)
What Does Schrodinger Inc (SDGR)’s 2026 Outlook Reveal?
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Schrodinger Reaffirms FY And Q2 2026 Financial And Operational Guidance
Morgan Stanley Maintains Equal-Weight on Schrodinger, Lowers Price Target to $17
Schrödinger, Inc. (SDGR) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Earnings Update: Schrödinger, Inc. (NASDAQ:SDGR) Just Reported And Analysts Are Trimming Their Forecasts
A Look At Schrödinger (NasdaqGS:SDGR) Valuation After Q1 Earnings And Hosted AI Software Push
Schrödinger, Inc. Q1 2026 Earnings Call Summary
Schrödinger, Inc. 2026 Q1 - Results - Earnings Call Presentation
Schrödinger Inc (NASDAQ:SDGR) Q1 2026 Earnings: Revenue Beat Fails to Offset Loss Miss, Stock Slides
Schrodinger, Inc. (SDGR) Reports Q1 Loss, Misses Revenue Estimates
Schrödinger, Inc. (SDGR) Q1 2026 Earnings Call Transcript
Schrödinger Reports First Quarter 2026 Financial Results
Schrodinger Affirms FY2026 Sales Guidance of $273.000M-$293.000M vs $252.752M Est
Schrodinger Q1 Adj. EPS $(0.63), Inline, Sales $58.587M Beat $48.002M Estimate
AI Revolutionizing Biopharma: Faster, Better, Cheaper
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.